search: results update below


browse funds: selections are stored



recently rated:

Rated by 27
3.3

top rated funds:

Rated by 12
4.5

Rated by 22
4.4

Rated by 11
4.2
 

Rated by 19
4.1

Rated by 39
4.0

Rated by 10
3.9

Rated by 30
3.9

Rated by 30
3.9

Rated by 63
3.8

Rated by 11
3.8

Rated by 43
3.8

Rated by 27
3.7

Rated by 105
3.7

Rated by 31
3.7

Rated by 11
3.6

Rated by 20
3.6

Rated by 16
3.6

Rated by 10
3.6
 

Rated by 62
3.6

Rated by 10
3.6

Rated by 20
3.5

Rated by 12
3.5
 

Rated by 18
3.4

Rated by 19
3.4

Rated by 14
3.4
 

Rated by 48
3.4
 

Rated by 31
3.4

Rated by 16
3.4
 

Rated by 11
3.4

Rated by 10
3.4

Please take a moment and make a financial contribution to TheFunded. If we have helped you, help us with resources to further grow the both the site and our entrepreneur training program, The Founder Institute.

PureTech Ventures  CERTIFIED

Firm Rating:

Rated 4.5 / 5.0 by 4
Track
Record
4.7
Operating
Competence
5.0
Pitching
Efficiency
4.3
Favorable
Deal Terms
4.5
Execution
Assistance
4.0

Firm Homepage:

FIRM OVERVIEW: Small Private VC founded in 2001 based out of Boston, USA (US East)

FIRM DESCRIPTION: PureTech is a venture creation company and incorporates elements of an entrepreneur, inventor and seed stage fund. PureTech stakes out emerging areas and brings together leading experts to proactively form companies.

TEAM MEMBERS: Ben Shapiro, Daphne Zohar, Frank Douglas, John Zabriskie, Robert Langer, Ron Cape,

3
Agree
0
Disagree

Pure Tech

Fund: PureTech Ventures

Posted by maf on 2007-09-12

PUBLIC:

PureTech Ventures spealizes in creating new ventures and finding the knowledgeable and sophisiticated early-stage funding to bring them into operation, albeit on a smaller scale than that of a more typical "VC" fund. They review an incredible number of opportunities per year, approaching a thousand, and start just a handful of new companies, so it is a very selective process they work through. A company started with PureTech has direct access to the "PureTech network" of investors and advisors which encompasses a large number of highly experienced and successful big pharma, biopharma and academic individuals. In addition, they are networked with the venture and pharma community for investment and partnership to a very extensive level. For a small newly formed company, access to this network is invaluable.

PRIVATE: Members Only (998 Characters)